These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24244639)

  • 1. Echocardiography, spirometry, and systemic acute-phase inflammatory proteins in smokers with COPD or CHF: an observational study.
    Beghé B; Verduri A; Bottazzi B; Stendardo M; Fucili A; Balduzzi S; Leuzzi C; Papi A; Mantovani A; Fabbri LM; Ceconi C; Boschetto P
    PLoS One; 2013; 8(11):e80166. PubMed ID: 24244639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrecognised ventricular dysfunction in COPD.
    Macchia A; Rodriguez Moncalvo JJ; Kleinert M; Comignani PD; Gimeno G; Arakaki D; Laffaye N; Fuselli JJ; Massolin HP; Gambarte J; Romero M; Tognoni G
    Eur Respir J; 2012 Jan; 39(1):51-8. PubMed ID: 21700606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of serum sialic acid and high-sensitivity C-reactive protein: markers of systemic inflammation in patients with chronic heart failure.
    Rajendiran KS; Ananthanarayanan RH; Satheesh S; Rajappa M
    Br J Biomed Sci; 2014; 71(1):29-32. PubMed ID: 24693572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.
    Abernethy A; Raza S; Sun JL; Anstrom KJ; Tracy R; Steiner J; VanBuren P; LeWinter MM
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29650706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
    Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction.
    López-Sánchez M; Muñoz-Esquerre M; Huertas D; Montes A; Molina-Molina M; Manresa F; Dorca J; Santos S
    Clin Respir J; 2017 Nov; 11(6):859-866. PubMed ID: 26663885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease.
    Kurt OK; Tosun M; Kurt EB; Talay F
    Inflammation; 2015 Feb; 38(1):89-93. PubMed ID: 25303877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
    Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.
    Boschetto P; Campo I; Stendardo M; Casimirri E; Tinelli C; Gorrini M; Ceconi C; Fucili A; Potena A; Papi A; Ballerin L; Fabbri LM; Luisetti M
    Eur J Clin Invest; 2013 Jun; 43(6):562-9. PubMed ID: 23590548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients.
    Huang YS; Feng YC; Zhang J; Bai L; Huang W; Li M; Sun Y
    Clin Interv Aging; 2015; 10():81-7. PubMed ID: 25565790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular dysfunction in relation with systemic inflammation in chronic obstructive pulmonary disease patients.
    Gulen ST; Eryilmaz U; Yilmaz M; Karadag F
    Korean J Intern Med; 2019 May; 34(3):569-578. PubMed ID: 30360021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.
    Garudadri S; Woodruff PG; Han MK; Curtis JL; Barr RG; Bleecker ER; Bowler RP; Comellas A; Cooper CB; Criner G; Dransfield MT; Hansel NN; Paine R; Krishnan JA; Peters SP; Hastie AT; Martinez FJ; O'Neal WK; Couper DJ; Alexis NE; Christenson SA
    Chest; 2019 May; 155(5):908-917. PubMed ID: 30684474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic markers for the development of adverse outcomes in patients with chronic obstructive pulmonary disease and chronic heart failure].
    Karoli NA; Borodkin AV; Kosheleva NA; Rebrov AP
    Kardiologiia; 2018 Sep; 58(Suppl 9):39-47. PubMed ID: 30312570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
    Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.
    Stanciu AE; Stanciu MM; Vatasescu RG
    Cytokine; 2018 Nov; 111():13-19. PubMed ID: 30098475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease.
    Nishimura K; Nishimura T; Onishi K; Oga T; Hasegawa Y; Jones PW
    Int J Chron Obstruct Pulmon Dis; 2014; 9():155-62. PubMed ID: 24523584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency thoracic ultrasound in the differentiation of the etiology of shortness of breath (ETUDES): sonographic B-lines and N-terminal pro-brain-type natriuretic peptide in diagnosing congestive heart failure.
    Liteplo AS; Marill KA; Villen T; Miller RM; Murray AF; Croft PE; Capp R; Noble VE
    Acad Emerg Med; 2009 Mar; 16(3):201-10. PubMed ID: 19183402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of plasma ghrelin in predicting the outcome of patients with chronic heart failure.
    Chen Y; Ji XW; Zhang AY; Lv JC; Zhang JG; Zhao CH
    Arch Med Res; 2014 Apr; 45(3):263-9. PubMed ID: 24508287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonale.
    Inoue Y; Kawayama T; Iwanaga T; Aizawa H
    Intern Med; 2009; 48(7):503-12. PubMed ID: 19336951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease.
    Andrijevic L; Milutinov S; Andrijevic I; Jokic D; Vukoja M
    Balkan Med J; 2017 May; 34(3):226-231. PubMed ID: 28443567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.